MRI in the detection of hepatic metastases from high-risk uveal melanoma: A prospective study in 188 patients

British Journal of Ophthalmology

Volumn 97, Issue 2, 2013, Pages 159-163

  Marshall, Ernie ^a   Romaniuk, Christopher ^a   Ghaneh, Paula ^b   Wong, Helen ^a   McKay, Marie ^a   Chopra, Mona ^a   Coupland, Sarah E ^b   Damato, Bertil E ^b  

^a CLATTERBRIDGE CENTRE FOR ONCOLOGY   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ANAMNESIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CLINICAL EXAMINATION; COHORT ANALYSIS; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LIVER FUNCTION TEST; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOFREQUENCY ABLATION; SURVIVAL TIME; SYSTEMIC DISEASE; TUMOR VOLUME; UVEA MELANOMA;

ADULT; AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; LIVER; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MELANOMA; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SURVIVAL RATE; UVEA; UVEAL NEOPLASMS; YOUNG ADULT;

EID: 84872930014     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2012-302323     Document Type: Article

References (21)

1. Kujala E, Makitie T, Kivelä T. Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sc 2003;44:4651-9. (Pubitemid 37315273)
2. Diener-West M, Reynolds SM, Agugliaro DJ, et al. Screening for metastasis from choroidal melanoma: the Collaborative Ocular Melanoma Study Group Report 23. J Clin Oncol 2004;22:2438-4. (Pubitemid 41115402)
3. Onken MD, Worley LA, Tuscan MD, et al. An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma. J Mol Diagn 2010;12:461-8.
4. Prescher G, Bornfeld N, Hirche H, et al. Prognostic implications of monosomy 3 in uveal melanoma. Lancet 1996;347:1222-5. (Pubitemid 26131850)
5. Damato B, Eleuteri A, Taktak AF, et al. Estimating prognosis for survival after treatment of choroidal melanoma. Prog Retin Eye Res 2011;30:285-95.
6. Eleuteri A, Damato B, Coupland SE, et al. Enhancing survival prognostication in patients with choroidal melanoma by integrating pathologic, clinical and genetic predictors of metastasis. IJBET 2012;8:18-35.
7. Kim IK, Lane AM, Gragoudas ES. Survival in patients with presymptomatic diagnosis of metastatic uveal melanoma. Arch Ophthalmol 2010;128:871-5.
8. Augsburger JJ, Correa ZM, Shaikh AH. Effectiveness of treatments for metastatic uveal melanoma. Am J Ophthalmol 2009;148:119-27.
9. van Etten B, de Wilt JH, Brunstein F, et al. Isolated hypoxic hepatic perfusion with melphalan in patients with irresectable ocular melanoma metastases. Eur J Surg Oncol 2009;35:539-45.
10. Kennedy AS, Nutting C, Jakobs T, et al. A first report of radioembolization for hepatic metastases from ocular melanoma. Cancer Invest 2009;27:682-90.
11. Mariani P, Piperno-Neumann S, Servois V, et al. Surgical management of liver metastases from uveal melanoma: 16 years' experience at the Institut Curie. Eur J Surg Oncol 2009;35:1192-7.
12. Damato B, Dopierala JA, Coupland SE. Genotypic profiling of 452 choroidal melanomas with multiplex ligation-dependent probe amplification. Clin Cancer Res 2010;16:6083-92.
13. Damato B, Duke C, Coupland SE, et al. Cytogenetics of uveal melanoma: a 7-year clinical experience. Ophthalmology 2007;114:1925-31.
14. Sandinha T, Hebbar G, Kenawy N, et al. A nurse-led ocular oncology clinic in Liverpool: results of a 6-month trial. EYE (Lond) 2012;26:937-43.
15. Orcurto V, Denys A, Voelter V, et al. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in patients with liver metastases from uveal melanoma: results from a pilot study. Melanoma Res 2012;22:63-9.
16. Servois V, Mariani P, Malhaire C, et al. Preoperative staging of liver metastases from uveal melanoma by magnetic resonance imaging (MRI) and fluorodeoxyglucosepositron emission tomography (FDG-PET). Eur J Surg Oncol 2010;36: 189-94.
17. Strobel K, Bode B, Dummer R, et al. Limited value of 18F-FDG PET/CT and S-100B tumour marker in the detection of liver metastases from uveal melanoma compared to liver metastases from cutaneous melanoma. Eur J Nucl Med Mol Imaging 2009;36:1774-82.
18. Patel M, Winston CB, Marr BP, et al. Characterization of computed tomography scan abnormalities in patients with biopsy-proven hepatic metastases from uveal melanoma. Arch Ophthalmol 2011;129:1576-82.
19. Eskelin S, Pyrhonen S, Summanen P, et al. Screening for metastatic malignant melanoma of the uvea revisited. Cancer 1999;85:1151-9. (Pubitemid 29115596)
20. Maeda T, Tateishi U, Suzuki S, et al. Magnetic resonance screening trial for hepatic metastasis in patients with locally controlled choroidal melanoma. Jpn J Clin Oncol 2007;37:282-6. (Pubitemid 47090680)
21. Whitehead J, Tishkovskaya S, O'Connor J, et al. Devising two-stage and multistage phase II studies on systemic adjuvant therapy for uveal melanoma. Invest Ophthalmol Vis Sc 2012;53:4986-9.